Exosomes derived from MSCs express “CD63, CD9 and CD81” to elicit TRAIL-mediated apoptosis in cancer cells in a dose-dependent fashion without cytotoxicity to human bronchial epithelial cells [130,131]. Here, CD63 is linked to cancer.